Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks.

Sharmistha Chakraborty | Li Li | Vineshkumar Thidil Puliyappadamba | Gao Guo | Kimmo J Hatanpaa | Bruce Mickey | Rhonda F Souza | Peggy Vo | Joachim Herz | Mei-Ru Chen | David A Boothman | Tej K Pandita | David H Wang | Ganes C Sen | Amyn A Habib
Nature communications | 2014

Epidermal growth factor receptor (EGFR) overexpression plays an important oncogenic role in cancer. Regular EGFR protein levels are increased in cancer cells and the receptor then becomes constitutively active. However, downstream signals generated by constitutively activated EGFR are unknown. Here we report that the overexpressed EGFR oscillates between two distinct and mutually exclusive modes of signalling. Constitutive or non-canonical EGFR signalling activates the transcription factor IRF3 leading to expression of IFI27, IFIT1 and TRAIL. Ligand-mediated activation of EGFR switches off IRF3-dependent transcription, activates canonical extracellular signal-regulated kinase (ERK) and Akt signals, and confers sensitivity to chemotherapy and virus-induced cell death. Mechanistically, the distinct downstream signals result from a switch of EGFR-associated proteins. EGFR constitutively complexes with IRF3 and TBK1 leading to TBK1 and IRF3 phosphorylation. Addition of epidermal growth factor dissociates TBK1, IRF3 and EGFR leading to a loss of IRF3 activity, Shc-EGFR association and ERK activation. Finally, we provide evidence for non-canonical EGFR signalling in glioblastoma.

Pubmed ID: 25503978

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA134571
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL063762
  • Agency: NCI NIH HHS, United States
    Id: R01-CA134571
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS062080
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK063621
  • Agency: NCI NIH HHS, United States
    Id: CA154320
  • Agency: NCI NIH HHS, United States
    Id: CA129537
  • Agency: NCI NIH HHS, United States
    Id: P30 CA142543
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000439
  • Agency: NCI NIH HHS, United States
    Id: R01 CA154320
  • Agency: BLRD VA, United States
    Id: I01 BX002559
  • Agency: NHLBI NIH HHS, United States
    Id: R37 HL063762
  • Agency: NIDDK NIH HHS, United States
    Id: R01-DK63621
  • Agency: NCI NIH HHS, United States
    Id: R01 CA129537
  • Agency: NCI NIH HHS, United States
    Id: R01 CA139217
  • Agency: NCI NIH HHS, United States
    Id: P01 CA062220
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI073303

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Primer3 (tool)

RRID:SCR_003139

Tool used to design PCR primers from DNA sequence - often in high-throughput genomics applications. It does everything from mispriming libraries to sequence quality data to the generation of internal oligos.

View all literature mentions

PrimerBank (tool)

RRID:SCR_006898

Database of human and mouse primer pairs for gene expression analysis by polymerase chain reaction (PCR) and quantitative PCR (qPCR). A total of 306,800 primers covering most known human and mouse genes can be accessed from the PrimerBank database, together with information on these primers such as T(m), location on the transcript and amplicon size. For each gene, at least one primer pair has been designed and in many cases alternative primer pairs exist. Primers have been designed to work under the same PCR conditions, thus facilitating high-throughput QPCR. All primers in PrimerBank were carefully designed to ensure gene specificity. All experimental validation data for mouse primers are available from PrimerBank. You can submit your primers. They will be added to the database once they are properly QCd.

View all literature mentions

Vector BioLabs (tool)

RRID:SCR_011010

Biotechnology company focused on developing robust gene delivery products, by using its proprietary technologies. Since 2004, we have worked with over 300 research labs in 20 different countries to provide gene delivery products and services using many viral platforms including recombinant adenoviruses, adeno-associated virus (AAV) and lentivirus.

View all literature mentions

MDA-MB-468 (tool)

RRID:CVCL_0419

Cell line MDA-MB-468 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

U-251MG (tool)

RRID:CVCL_0021

Cell line U-251MG is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

MDA-MB-468 (tool)

RRID:CVCL_0419

Cell line MDA-MB-468 is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions

U-87MG ATCC (tool)

RRID:CVCL_0022

Cell line U-87MG ATCC is a Cancer cell line with a species of origin Homo sapiens (Human)

View all literature mentions